胶质母细胞瘤切除肿瘤体积与位置对患者结局的影响
该回顾性队列纳入2006年1月至2011年12月接受标准化术后放化疗的330例成人胶质母细胞瘤患者,分析术前术后MRI肿瘤体积与位置对总生存的影响。调整混杂因素后,切除程度单独与总生存无关,术前肿瘤体积、年龄、多灶性和深部核团/基底节位置是生存不良的最强预测因素;切除程度与术前体积的交互项(代表减少的疾病负荷)是重要预测因素。
要点
- 术前肿瘤体积较大(HR 1.05,95%CI 1.02-1.07)和年龄较大(HR 1.02,95%CI 1.01-1.03)与生存不良相关。
- 多灶性(HR 1.44,95%CI 1.01-2.04)和深部核团/基底节位置(HR 2.05,95%CI 1.27-3.3)为生存不良的最强预测因素。
- 调整其他因素后切除程度单独与总生存无关,但切除程度与术前体积的交互项(代表减少的疾病负荷)是重要预测因素。
核心结论
- 调整术前肿瘤体积、年龄和深部核团/基底节位置后,切除程度单独不是胶质母细胞瘤治疗中结局的重要预测因素。
- 切除程度与术前体积的交互项(代表减少的疾病负荷)是降低总生存的重要预测因素。
- 从 eloquent cortex 切除肿瘤未影响术后KPS。
- 这些结果提示,在给定肿瘤大小和位置下,积极的手术治疗以减少术后残留同时维持术后KPS可能有助于患者生存结局。
研究设计与样本
- 回顾性病历审查,纳入2006年1月至2011年12月接受治疗的成人胶质母细胞瘤患者,以遵守标准化术后放化疗方案为纳入标准。
- 471例筛选患者中141例因不符合全部纳入标准被排除,剩余330例(60.6%男性)纳入分析。
- 对术前和术后即刻磁共振成像进行详细体积和位置分析,采用Cox比例风险模型探索切除程度和 eloquent location 的修正效应。
主要发现
- 330例患者平均(±SD)年龄58.9±12.9岁,术前和术后Karnofsky功能状态评分(KPS)均值分别为76.2±10.3和80.0±16.6。
- 术前肿瘤体积平均33.2±29.0 ml,术后残留4.0±8.1 ml,平均切除程度88.6±17.6%;观察到的平均随访17.6±15.7个月,平均总生存16.7±14.4个月。
- 脑室周围位置(16.8±1.7 vs. 21.5±1.4个月,p=0.03)、深部核团/基底节(11.6±1.7 vs. 20.6±1.2个月,p=0.002)和多灶性(12.0±1.4 vs. 21.3±1.3个月,p=0.0001)患者生存显著缩短,而 eloquent cortex 部位对生存无显著影响(p=0.14,所有单个位置范围0.07-0.9)。
- 单变量分析中总生存随切除程度显著改善,>90%、80-90%和70-80%切除的平均总生存分别为22.3、19.7和13.2个月;术后残留0、0-5和5-10 ml的总生存分别为22.8、19.0和12.7个月。
- 风险模型显示,调整KPS和肿瘤位置后,较大术前肿瘤体积(HR 1.05,95%CI 1.02-1.07)、较大年龄(HR 1.02,95%CI 1.01-1.03)、多灶性(HR 1.44,95%CI 1.01-2.04)和深部核团/基底节(HR 2.05,95%CI 1.27-3.3)是最能预测生存不良的因素;切除程度与术前肿瘤体积间存在微小但显著的交互作用(HR 0.9995,95%CI 0.9993-0.9998),但调整其他因素后切除程度单独与总生存无关。
关键数值与推荐
- 较大术前肿瘤体积:HR 1.05,95%CI 1.02-1.07。
- 较大年龄:HR 1.02,95%CI 1.01-1.03。
- 多灶性:HR 1.44,95%CI 1.01-2.04。
- 深部核团/基底节位置:HR 2.05,95%CI 1.27-3.3。
- 切除程度与术前肿瘤体积交互项:HR 0.9995,95%CI 0.9993-0.9998。
临床怎么用
- 作者认为,在给定肿瘤大小和位置下,积极的手术治疗以减少术后残留同时维持术后KPS可能有助于患者生存结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastoma is an aggressive primary brain tumor with devastatingly poor prognosis. Multiple studies have shown the benefit of wider extent of resection (EOR) on patient overall survival (OS) and worsened survival with larger preoperative tumor volumes. However, the concomitant impact of postoperative tumor volume and eloquent location on OS has yet to be fully evaluated. We performed a retrospective chart review of adult patients treated for glioblastoma from January 2006 through December 2011. Adherence to standardized postoperative chemoradiation protocols was used as an inclusion criterion. Detailed volumetric and location analysis was performed on immediate preoperative and immediate postoperative magnetic resonance imaging. Cox proportional hazard modeling approach was employed to explore the modifying effects of EOR and eloquent location after adjusting for various confounders and associated characteristics, such as preoperative tumor volume and demographics. Of the 471 screened patients, 141 were excluded because they did not meet all inclusion criteria. The mean (±SD) age of the remaining 330 patients (60.6% male) was 58.9 ± 12.9 years; the mean preoperative and postoperative Karnofsky performance scores (KPSs) were 76.2 ± 10.3 and 80.0 ± 16.6, respectively. Preoperative tumor volume averaged 33.2 ± 29.0 ml, postoperative residual was 4.0 ± 8.1 ml, and average EOR was 88.6 ± 17.6%. The observed average follow-up was 17.6 ± 15.7 months, and mean OS was 16.7 ± 14.4 months. Survival analysis showed significantly shorter survival for patients with lesions in periventricular (16.8 ± 1.7 vs. 21.5 ± 1.4 mo, p = 0.03), deep nuclei/basal ganglia (11.6 ± 1.7 vs. 20.6 ± 1.2, p = 0.002), and multifocal (12.0 ± 1.4 vs. 21.3 ± 1.3 months, p = 0.0001) locations, but no significant influence on survival was seen for eloquent cortex sites (p = 0.14, range 0.07-0.9 for all individual locations). OS significantly improved with EOR in univariate analysis, averaging 22.3, 19.7, and 13.2 months for >90, 80-90, and 70-80% resection, respectively. Survival was 22.8, 19.0, and 12.7 months for 0, 0-5, and 5-10 ml postoperative residual, respectively. A hazard model showed that larger preoperative tumor volume [hazard ratio (HR) 1.05, 95% CI 1.02-1.07], greater age (HR 1.02, 95% CI 1.01-1.03), multifocality (HR 1.44, 95% CI 1.01-2.04), and deep nuclei/basal ganglia (HR 2.05, CI 1.27-3.3) were the most predictive of poor survival after adjusting for KPS and tumor location. There was a negligible but significant interaction between EOR and preoperative tumor volume (HR 0.9995, 95% CI 0.9993-0.9998), but EOR alone did not correlate with OS after adjusting for other factors. The interaction between EOR and preoperative tumor volume represented tumor volume removed during surgery. In conclusion, EOR alone was not an important predictor of outcome during GBM treatment once preoperative tumor volume, age, and deep nuclei/basal ganglia location were factored. Instead, the interaction between EOR and preoperative volume, representing reduced disease burden, was an important predictor of reducing OS. Removal of tumor from eloquent cortex did not impact postoperative KPS. These results suggest aggressive surgical treatment to reduce postoperative residual while maintaining postoperative KPS may aid patient survival outcomes for a given tumor size and location.
引用
- Awad AW, Karsy M, Sanai N, et al. Impact of removed tumor volume and location on patient outcome in glioblastoma. J Neurooncol. 2017. PMID: 28685405. doi:10.1007/s11060-017-2562-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。